July 23, 2026

Press Release: Proactive support to quit tobacco use during cancer treatment doubles quit rates in a nationwide trial

July 15, 2026

Press Release: ECOG-ACRIN ENDURANCE trial findings published in the New England Journal of Medicine provide the first randomized evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

June 10, 2026

Press Release: Elsa Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN 2026 scientific leadership and mentorship awards

May 21, 2026

Press Release: Guide to ECOG-ACRIN cancer research at ASCO 2026

May 19, 2026

Press Release: TAILORx and RxPONDER trials shift to a discovery platform for analyzing breast cancer recurrence using advanced tumor profiling and AI

March 19, 2026

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

March 4, 2026

Press Release: ECOG-ACRIN Cancer Research Group announces the retirement of Robert Gray after 25 years as group statistician

December 11, 2025

Press Release: An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

December 10, 2025

Press Release: ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

ECOG-ACRIN Cancer Research Group